Where Trusted Expertise Meets Real-World Impact
AscellaHealth is at the forefront of change, partnering with stakeholders across the health services industry to elevate and transform the patient journey. Stay up to date with the latest news, events, and media coverage as we continue to shape the future of healthcare.
Search
Search
Sort By
Newsroom
ClearCategories
ClearHealthcare—
Together
AscellaHealth Inaugurates Strategic Advisory Council, With Founding Members, Advances Pharmacy Benefits Ecosystem Through Technology Deployment and Specialty Expertise
AscellaHealth, today announced the formation of its Strategic Advisory Council (ASAC), appointing its initial founding members representing key areas of the payer landscape, with additional members to be announced as the council expands.
AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List
AscellaHealth has been named to the Financial Times’ list of the Americas’ Fastest Growing Companies 2026 for the fourth consecutive year. The award is presented by the Financial Times in collaboration with Statista Inc., a world-leading provider of market and consumer data.
Costs are spiking for specialty drugs. How are employers and insurers handling it?
The trouble for employers centers on a group of drugs typically needed by about 2% of the plan members, but that accounts for more than half of pharmaceutical costs.
Beyond the Balance Sheet: The Sacred Responsibility of Healthcare CFOs in Today’s Oncology Landscape
As cancer incidence rises and therapeutic complexity grows, the role of healthcare CFOs and clinicians becomes increasingly central.
AscellaHealth Expands International Operations, Broadens Executive Leadership to Accelerate Global Market Access for Life Sciences
DUBLIN and BERWYN, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces expanded leadership roles for Gillian Molloy, general manager, AscellaHealth international operations, and Alexis Moss, vice president of commercial, AscellaHealth international business. Molloy and Moss, based in Dublin and London respectively, will lead growth in the EU, UK and Middle East as the company continues to expand international market access and advance patient-centric solutions across its worldwide operations.
AscellaHealth Launches Strategic Pharmacy Benefits Enablement Platform to Address 2026 Healthcare Cost and Access Challenges
BERWYN, Pa., Jan. 14, 2026 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions for the specialty pharmaceutical industry, today announced the launch of AscellaOne™, a technology-driven strategic enablement platform designed to modernize how health plans, employers and PBM organizations administer and manage pharmacy benefits.
CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Celebrates 50 Years of Global Pharmaceutical Excellence
WATFORD, United Kingdom and BERWYN, Pa., Oct. 13, 2025 (GLOBE NEWSWIRE) -- CHAPPER healthcare, AscellaHealth’s global pharmaceutical wholesaler, distributor, and service provider, proudly celebrates its 50th anniversary—marking five decades of delivering critical access to licensed and unlicensed medicines to patients in more than 80 countries across six continents.